Comparison of Clinical Outcomes between del Nido Cardioplegia and Microplegia among Patients Undergoing Elective Mitral Valve Replacement

被引:1
|
作者
Hafiz, Erhan [1 ]
Altinbas, Ozgur [2 ]
Kutlu, Isik Betil [1 ]
Moda, Mehmet [1 ]
Celkan, Mehmet Adnan [1 ]
机构
[1] Gaziantep Univ, Dept Cardiovasc Surg, Med Fac, TR-27410 Gaziantep, Turkiye
[2] Gaziantep Univ, Dept Operat Room Serv, Vocat Sch Hlth Serv, TR-27310 Gaziantep, Turkiye
来源
HEART SURGERY FORUM | 2023年 / 26卷 / 06期
关键词
cardioplegia; del Nido; microplegia; mitral valve replacement; ADULT CARDIAC-SURGERY; BLOOD CARDIOPLEGIA; MYOCARDIAL PROTECTION;
D O I
10.59958/hsf.6381
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cardioplegia solutions are used to protect the myocardium from ischemic injury caused by cardiopulmonary bypass and various types of cardioplegia solutions have been introduced for cardiac surgery. In this study, we aimed to compare the effects of del Nido cardioplegia and microplegia, which were mostly used in our clinic for intraoperative and postoperative processes among patients who underwent elective mitral valve replacement. As a result, the comparison could be performed in a specific patient group without additional valvular or coronary disease, and cardioplegia distribution could be achieved more efficiently. Methods: Between 2018 and 2023, a total of 120 patients who underwent elective mitral valve replacement via sternotomy with del Nido cardioplegia or microplegia were included in the study. Patients were divided into two groups; group 1 (del Nido, n = 64) and group 2 (microplegia, n = 56). Preoperative characteristics, intraoperative and postoperative early clinical data as primary outcomes, and postoperative mortality rates and intensive care costs as secondary outcomes were compared statistically. Results: There were no statistically significant differences in terms of preoperative characteristics between the two groups. Duration of cross clamp differences between group 1 versus group 2 (45 +/- 16 vs. 57 +/- 19 min), cardiopulmonary bypass (56 +/- 17 vs. 65 +/- 21 min), intensive care length of stay (18.04 +/- 7.41 vs. 22.37 +/- 6.86 h), requirement of intraoperative defibrillation (n = 5 vs. n = 13), and intensive care costs were found to be statistically significantly lower in del Nido group. Conclusion: Either del Nido or microplegia solutions can be used safely in mitral valve replacement operations, however, del Nido cardioplegia has some advantages over intraoperative processes, such as lowering the cross clamp and cardiopulmonary bypass time. Furthermore, patients who received del Nido cardioplegia had shorter intensive care stay and required less intraoperative defibrillation compared with the microplegia group. Therefore, less exposure to anesthesia, the prevention of infection due to shortened operation duration, and greater costeffectiveness can be achieved by using del Nido cardioplegia instead of microplegia.
引用
收藏
页码:E826 / E831
页数:6
相关论文
共 50 条
  • [21] Comparison of Del Nido Cardioplegia and Blood Cardioplegia in Terms of Development of Postoperative Atrial Fibrillation in Patients Undergoing Isolated Coronary Artery Bypass Grafting
    Sanri, Umut Serhat
    Ozsin, Kadir Kaan
    Toktas, Faruk
    Yavuz, Senol
    BRAZILIAN JOURNAL OF CARDIOVASCULAR SURGERY, 2021, 36 (02) : 158 - 164
  • [22] Outcomes and clinical impact of mitral regurgitation in patients with aortic stenosis undergoing with transcatheter aortic valve replacement
    Munoz-Garcia, E.
    Munoz-Garcia, M.
    Munoz Garcia, A. J.
    Dominguez-Franco, A. J.
    Carrasco-Chinchilla, F.
    Alonso-Briales, J. H.
    Hernandez-Garcia, J. M.
    Gomez-Doblas, J. J.
    Jimenez-Navarro, M. F.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3448 - 3448
  • [23] Outcomes of Patients Undergoing Third-Time Aortic or Mitral Valve Replacement
    Elhmidi, Yacine
    Guenzinger, Ralf
    Deutsch, Marcus-Andre
    Badiu, Catalin Constantin
    Krane, Markus
    Lange, Ruediger
    JOURNAL OF CARDIAC SURGERY, 2014, 29 (01) : 8 - 13
  • [24] Characteristics and outcomes of patients undergoing transcatheter mitral valve replacement with the Tendyne system
    Wilde, Nihal
    Tenaka, Tetsu
    Vij, Vivian
    Sugiura, Atsushi
    Sudo, Mitsumasa
    Eicheler, Eva
    Silaschi, Miriam
    Vogelhuber, Johanna
    Bakhtiary, Farhad
    Nickenig, Georg
    Weber, Marcel
    Zimmer, Sebastian
    CLINICAL RESEARCH IN CARDIOLOGY, 2024, 113 (01) : 1 - 10
  • [25] Role of Prophylactic N-Acetylcysteine Supplementation on Postoperative Outcomes in Patients Undergoing Elective Double-Valve Replacement (Aortic and Mitral Valve)
    Kiran, K. S. Ram
    Trivedi, Visharad
    Rajesh, Venuthurupalli S. P.
    Sharma, Manisha
    Haranal, Maruti
    Pandya, Himani
    ANNALS OF CARDIAC ANAESTHESIA, 2024, 27 (04) : 324 - 329
  • [26] Comparison of Early Outcomes in Del Nido Cardioplegia Versus Conventional Cardioplegia in Term of Myocardial Protection in Patients with A Preserved Left Ventricular Function Undergoing Coronary Artery Bypass Grafting (CABG)
    Rahim, Syed Sardar
    Khan, Ahmad Kamran
    Salman, Malik
    Pannu, Furqan Yaqub
    Ahmed, Bilal
    Iqbal, Shahid
    Shafqat, Amna
    Afshan, Shamila
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (12): : 3373 - 3374
  • [27] Comparison between Custodiol, del Nido and modified del Nido in the myocardial protection-Cardioplegia Trial: a study protocol for a randomised, double-blind clinical trial
    Almeida, Adriana Silveira
    Ceron, Rafael Oliveira
    Anschau, Fernando
    Kopittke, Luciane
    Lira, Kathize Betti
    Delvaux, Renan Senandes
    Rode, Juarez
    Widholzer Rey, Rafael Antonio
    Wittke, Estefania Ines
    Rombaldi, Alfeu Roberto
    BMJ OPEN, 2021, 11 (09):
  • [28] Comparison of del Nido and histidine-tryptophan-ketoglutarate cardioplegia solutions in pediatric patients undergoing open heart surgery: A prospective randomized clinical trial
    del Nido, Pedro J.
    Talwar, Sachin
    Romano, Jennifer
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 157 (03): : 1191 - 1192
  • [29] Clinical Outcomes of Patients Anatomically Unsuitable for Transcatheter Mitral Valve Replacement
    Guo, Yuchao
    Patel, Vivek
    Goyal, Ayush
    Basantes, Jair
    Singh, Uttam
    Ahlawat, Prashant
    Upadhyay, Prateek
    Garg, Tulika
    Madaan, Prateek
    Arakelyan, Artur
    Patel, Dhairya
    Nagasaka, Takashi
    Suruga, Kazuki
    Hidemasa, Shitan
    Koren, Ofir
    Gheorgiu, Mitch
    Stegic, Jasminka
    Harutyunyan, Izabela
    Friedman, Michelle
    Salseth, Tracy
    Cole, Brittany
    Vuong, Tina
    Chakravarty, Tarun
    Nakamura, Mamoo
    Gupta, Aakriti
    Makar, Moody
    Hassan, Daniel Zumerkorn
    Skaf, Sabah
    Cheng, Wen
    Jilaihawi, Hasan
    Makkar, Raj
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (18) : B229 - B230
  • [30] Association Between Red Blood Cell Transfusion and Clinical Outcomes Among Patients Undergoing Transcatheter Aortic Valve Replacement
    Apostolidou, Eirini
    Aronow, Herbert D.
    Beale, Charles E.
    Kolte, Dhaval
    Kennedy, Kevin F.
    Sellke, Frank W.
    Gordon, Paul C.
    Sharaf, Barry
    Ehsan, Afshin
    ANNALS OF THORACIC SURGERY, 2019, 107 (06): : 1791 - 1798